RITLECITINIB | RITLECITINIB | ATC L04AF08
ANTINEOPLASTIC JANUS KINASE 3 (JAK3) KINASE INHIBITOR TREATMENT OF SEVERE ALOPECIA AREATA IN ADULTS AND ADOLESCENTS 12 YEARS AND OLDER | ORAL | Tmax 1 HOUR F 64 PERCENT PPB 14 PERCENT HT 1.8 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | JANUS KINASE 3 (JAK3) | Tyrosine-protein kinase JAK3 UNIPROT P52333 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |